CN114931171A - 一种消炎、配比平衡的复合脂肪酸的营养品 - Google Patents
一种消炎、配比平衡的复合脂肪酸的营养品 Download PDFInfo
- Publication number
- CN114931171A CN114931171A CN202210472312.7A CN202210472312A CN114931171A CN 114931171 A CN114931171 A CN 114931171A CN 202210472312 A CN202210472312 A CN 202210472312A CN 114931171 A CN114931171 A CN 114931171A
- Authority
- CN
- China
- Prior art keywords
- oil
- inflammatory
- fatty acid
- balanced
- nutriment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000014113 dietary fatty acids Nutrition 0.000 title claims abstract description 11
- 229930195729 fatty acid Natural products 0.000 title claims abstract description 11
- 239000000194 fatty acid Substances 0.000 title claims abstract description 11
- 230000003110 anti-inflammatory effect Effects 0.000 title claims abstract description 10
- -1 compound fatty acid Chemical class 0.000 title claims abstract description 8
- 239000003921 oil Substances 0.000 claims abstract description 17
- 235000019198 oils Nutrition 0.000 claims abstract description 17
- 239000003240 coconut oil Substances 0.000 claims abstract description 11
- 235000019864 coconut oil Nutrition 0.000 claims abstract description 11
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims abstract description 7
- 239000001335 perilla frutescens leaf extract Substances 0.000 claims abstract description 7
- JBYXPOFIGCOSSB-GOJKSUSPSA-N 9-cis,11-trans-octadecadienoic acid Chemical compound CCCCCC\C=C\C=C/CCCCCCCC(O)=O JBYXPOFIGCOSSB-GOJKSUSPSA-N 0.000 claims abstract description 6
- 229940108924 conjugated linoleic acid Drugs 0.000 claims abstract description 6
- 235000021388 linseed oil Nutrition 0.000 claims abstract description 6
- 239000000944 linseed oil Substances 0.000 claims abstract description 6
- 239000004006 olive oil Substances 0.000 claims abstract description 5
- 235000008390 olive oil Nutrition 0.000 claims abstract description 5
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims abstract description 5
- 241001300674 Plukenetia volubilis Species 0.000 claims description 6
- 150000004665 fatty acids Chemical class 0.000 claims description 3
- 235000016709 nutrition Nutrition 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 235000015097 nutrients Nutrition 0.000 claims 2
- 238000003825 pressing Methods 0.000 claims 2
- 238000002360 preparation method Methods 0.000 claims 1
- 241001438931 Embelia laeta Species 0.000 abstract 1
- 210000004556 brain Anatomy 0.000 description 7
- 239000003925 fat Substances 0.000 description 7
- 235000019197 fats Nutrition 0.000 description 7
- 206010061218 Inflammation Diseases 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 208000024172 Cardiovascular disease Diseases 0.000 description 4
- 210000000170 cell membrane Anatomy 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 4
- 150000003180 prostaglandins Chemical class 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 201000001320 Atherosclerosis Diseases 0.000 description 3
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 235000004626 essential fatty acids Nutrition 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000000446 fuel Substances 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 229960004488 linolenic acid Drugs 0.000 description 3
- 150000004667 medium chain fatty acids Chemical class 0.000 description 3
- 210000000653 nervous system Anatomy 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 208000024827 Alzheimer disease Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010039966 Senile dementia Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 201000001883 cholelithiasis Diseases 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 210000002249 digestive system Anatomy 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 235000021323 fish oil Nutrition 0.000 description 2
- 239000004519 grease Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000002858 neurotransmitter agent Substances 0.000 description 2
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000029865 regulation of blood pressure Effects 0.000 description 2
- 150000004671 saturated fatty acids Chemical class 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 208000020154 Acnes Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 1
- 240000000712 Casimiroa edulis Species 0.000 description 1
- 235000003936 Casimiroa edulis Nutrition 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 208000010445 Chilblains Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 206010025476 Malabsorption Diseases 0.000 description 1
- 208000004155 Malabsorption Syndromes Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 201000009053 Neurodermatitis Diseases 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 1
- 206010040954 Skin wrinkling Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037182 bone density Effects 0.000 description 1
- 230000004641 brain development Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000002192 cholecystectomy Methods 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 230000001149 cognitive effect Effects 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 231100000508 hormonal effect Toxicity 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 229940057917 medium chain triglycerides Drugs 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000004898 mitochondrial function Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021301 omega-3 deficiency Nutrition 0.000 description 1
- 229940012843 omega-3 fatty acid Drugs 0.000 description 1
- 210000001328 optic nerve Anatomy 0.000 description 1
- 239000010461 other edible oil Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 235000021003 saturated fats Nutrition 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 231100000075 skin burn Toxicity 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 230000037078 sports performance Effects 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000004260 weight control Methods 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
- A23D9/007—Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
Landscapes
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
本发明公开了一种消炎、配比平衡的复合脂肪酸的营养品，包括包括：亚麻籽油24％、橄榄油19％、椰子油17％、紫苏籽油16％、中链甘油三酯13％、美藤果油9％、共轭亚油酸2％。本发明的有益效果是，结构简单，实用性强。
Description
技术领域
本发明涉及营养品领域，特别是一种消炎、配比平衡的复合脂肪酸的营养品。
背景技术
人的神经系统有70％的成分是油脂，人体有大概60兆个细胞，油脂也是细胞膜的重要组成部分(占50％)。
成人日常饮食中，碳水化合物不可超过每日热量来源的50％，而油脂不可低于热量来源的40％，至于蛋白质，则只要10％就够了。而Omega3、6、9好油是构建人体大脑及腹脑(肠道)的必须原料。
Omega-3、6、9除了同饱和脂肪酸一样，可以作为燃料之外，也是细胞膜、神经组织的主要成分，更是构成成百上千种神经传导素及激素的原料前驱物质；
Omega-3、6、9可合成对健康具有关键性影响的前列腺素:据研究指出,人体内的多不饱和脂肪酸Omega-6太多或Omega-3缺乏，会导致长期发炎、癌症的扩散、心脏病、关节炎及免疫系统失调等疾病。
食物中如果含过量的Omega-6会促使体内炎症的发生，而Omega-3则有提高对抗炎症的效果。因此Omega-6过量被视为有害的，Omega-3则被认为对身体有利。事实上两者皆有其必需性，如何维持平衡才是焦点。要了解两者平衡的重要性，必须明白这两种必需脂肪酸在体内转化成前列腺素的原理所在，多不饱和脂肪酸是合成前列腺素的绝对必需原料，前列腺素是一种高度活跃，有类似激素般作用的物质。我们所摄取的脂肪酸经过一连串反应步骤:在身体内任何地方都可合成前列腺素，并参与调节血压、心跳、血管的扩张、中枢神经系统、血液凝固、水分平衡、皮肤健康、消化系统及肝脏功能健全等等，由前列腺素的重要功能可以理解,为何多不饱和脂肪酸被称为是“必需的”,甚至被称为维生素F。
发明内容
本发明的目的是为了解决上述问题，设计了一种消炎、配比平衡的复合脂肪酸的营养品。
实现上述目的本发明的技术方案为，一种消炎、配比平衡的复合脂肪酸的营养品，复包括：亚麻籽油24％、橄榄油19％、椰子油17％、紫苏籽油16％、中链甘油三酯13％、美藤果油9％、共轭亚油酸2％。
利用本发明的技术方案制作的消炎、配比平衡的复合脂肪酸的营养品，1、促进血液循环
2、改善消化系统功能
3、保护皮肤
4、提高内分泌系统功能
5、对骨骼系统的益处
6、防癌作用
7、防辐射作用
8、抗衰老
9、预防心脑血管疾病
10、降血压
11、抗菌消炎
附图说明
图1是常见食用油比例；
图2是人体大脑脂肪含量；
具体实施方式
下面结合附图对本发明进行具体描述，如图1-2所示，一种消炎、配比平衡的复合脂肪酸的营养品。
人的神经系统有70％的成分是油脂，人体有大概60兆个细胞，油脂也是细胞膜的重要组成部分(占50％)。
成人日常饮食中，碳水化合物不可超过每日热量来源的50％，而油脂不可低于热量来源的40％，至于蛋白质，则只要10％就够了。而Omega3、6、9好油是构建人体大脑及腹脑(肠道)的必须原料。
Omega-3、6、9除了同饱和脂肪酸一样，可以作为燃料之外，也是细胞膜、神经组织的主要成分，更是构成成百上千种神经传导素及激素的原料前驱物质。
本技术方案为，每袋15ml：亚麻籽油24％、橄榄油19％、椰子油17％、紫苏籽油16％、中链甘油三酯13％、美藤果油9％、共轭亚油酸2％。
亚麻籽油亚麻籽油中α-亚麻酸含量为53％，α-亚麻酸是人体必需脂肪酸，在人体内可转化为EPA和DHA，它们是鱼油中的有效活性成分。
亚麻籽油的功效与作用
1.预防心脑血管病
2.降血脂
3.降低临界性高血压
4.抑制癌症的发生和转移
5.抑制过敏反应、抗炎作用
6.抑制衰老
紫苏籽油
紫苏籽油所含主要成份为α-亚麻酸，含量高达67％左右，是目前所发现的所有天然植物油中Omega-3脂肪酸含量最高的，享有“陆地上的深海鱼油”美名。
长期食用紫苏籽油：
1.增加脑部营养、健脑益智、调节脑神经和视神经功能；
2.调节高血压、高血脂、降低胆固醇；
3.防止动脉粥样硬化、抑制血栓形成；
4.降低脑血栓及心血管病的发作；
5.增强人体免疫功能；
6.调节机体代谢、延缓机体衰老；
7.减缓并防止老年痴呆症的发生；
8.预防脂肪肝和糖尿病；
9.对保健肌肤和减肥也有较好效果。
美藤果油
美藤果油中不饱和脂肪酸含量高达92％以上，其中亚麻酸含量为48％，亚油酸含量为35％，油酸含量为9％，配比接近于人体最佳吸收比例。美藤果油可以有效的清除体内堆积的油脂，从而起到降低血压、降低血脂的作用。而且这种美藤果油中的维生素C含量非常丰富，可以美白皮肤、清除颜面部位的色素沉着。美藤果油中含有一定的DHA，可以有效的改善记忆力，对于老年痴呆有预防作用。
对大脑发育、免疫系统功能和血压调节有重要作用。
椰子油
椰子油是日常食物中唯一一种由中链脂肪酸组成的油脂，容易被人体消化吸收，椰子油对人体具有一定功效：
1、迅速为机体提供能量：椰子油的消化不需要动用人体的消化酶系统，而且肝脏更倾向于使用中链脂肪酸作为产能的燃料来源，进而提高新陈代谢的效率；
2、抗菌：椰子油是由中链脂肪酸组成的油脂，中链脂肪酸具有天然的综合抗菌能力，可以起到杀死引起疾病的细菌、病毒、真菌以及寄生虫的作用，可用于治疗神经性皮炎、冻疮等；
3、美容：椰子油属于饱和脂肪，有较强的抗氧化能力，可以防止自由基产生，而且椰子油内服外用都可以滋润皮肤、调整皮脂腺分泌，从而改善干燥的肤质，还能够帮助消除皱纹、粉刺、头皮屑等；
4、促进消化吸收：椰子油相比其他食用油更容易水解、消化吸收，适合消化障碍以及虚弱体质的人群食用，比如胆囊切除、胆囊炎、胆结石、胰腺炎等人群可以食用椰子油。
中链甘油三酯(MCT)
MCT通常可作为手术后、感染和皮肤烧伤病人的专用食品，还可用于那些患有脂肪吸收不良，艾滋病人和癌症病人、糖尿病人的食品，可用于治疗前列腺增生、消散胆石、降低胆固醇、防治高血脂症等。
改善认知和神经系统功能。
改善线粒体功能，并由此降低多种疾病的患病风险，如动脉粥样硬化、糖尿病、癌症、心血管疾病、自体免疫性疾病和癫痫。
优化能量水平，提高运动表现。
有助于清除肠道内的有害微生物，如致病菌、病毒、真菌和寄生虫。和椰子油一样，MCT同样具有抗氧化和抗炎的功效。
此外还可以帮助减肥，实践证明，食用MCT对人体的体重、腹部脂肪面积的减少、腰围的减少，均有明显的效果。
橄榄油在西方被誉为“液体黄金”，“植物油皇后”。
共轭亚油酸甘油酯
具有抗肿瘤、抗氧化、抗动脉粥样硬化、提高免疫力、提高骨骼密度、防治糖尿病等多种重要生理功能；而且还能降低动物和人体胆固醇以及甘油三酯和低密度脂蛋白胆固醇、还可以降低动物和人体脂肪、增加肌肉。共轭亚油酸进入机体后能够增加体能消耗，因此在体重控制方面可以有效降低体内脂肪沉积。
上述技术方案仅体现了本发明技术方案的优选技术方案，本技术领域的技术人员对其中某些部分所可能做出的一些变动均体现了本发明的原理，属于本发明的保护范围之内。
Claims (2)
1.一种消炎、配比平衡的复合脂肪酸的营养品，其特征在于，包括：亚麻籽油24％、橄榄油19％、椰子油17％、紫苏籽油16％、中链甘油三酯13％、美藤果油9％、共轭亚油酸2％。
2.制造一种消炎、配比平衡的复合脂肪酸的营养品的制备工艺，其特征在于，所述营养品采用初榨、冷榨的生产工艺。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210472312.7A CN114931171A (zh) | 2022-04-29 | 2022-04-29 | 一种消炎、配比平衡的复合脂肪酸的营养品 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210472312.7A CN114931171A (zh) | 2022-04-29 | 2022-04-29 | 一种消炎、配比平衡的复合脂肪酸的营养品 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114931171A true CN114931171A (zh) | 2022-08-23 |
Family
ID=82863631
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210472312.7A Pending CN114931171A (zh) | 2022-04-29 | 2022-04-29 | 一种消炎、配比平衡的复合脂肪酸的营养品 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114931171A (zh) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1748540A (zh) * | 2005-10-17 | 2006-03-22 | 山西省农业科学院农产品综合利用研究所 | 营养平衡的植物调和油 |
| CN105053256A (zh) * | 2015-07-29 | 2015-11-18 | 广州金酮医疗科技有限公司 | 一种风味型营养均衡调和油 |
| CN106509160A (zh) * | 2016-10-14 | 2017-03-22 | 广西放心源生物科技有限公司 | 一种食用调和油 |
| CN109939078A (zh) * | 2019-05-05 | 2019-06-28 | 哈尔滨希碧迪医药科技开发有限公司 | 一种含有桦木酸的辅助降血脂软胶囊的制备方法 |
-
2022
- 2022-04-29 CN CN202210472312.7A patent/CN114931171A/zh active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1748540A (zh) * | 2005-10-17 | 2006-03-22 | 山西省农业科学院农产品综合利用研究所 | 营养平衡的植物调和油 |
| CN105053256A (zh) * | 2015-07-29 | 2015-11-18 | 广州金酮医疗科技有限公司 | 一种风味型营养均衡调和油 |
| CN106509160A (zh) * | 2016-10-14 | 2017-03-22 | 广西放心源生物科技有限公司 | 一种食用调和油 |
| CN109939078A (zh) * | 2019-05-05 | 2019-06-28 | 哈尔滨希碧迪医药科技开发有限公司 | 一种含有桦木酸的辅助降血脂软胶囊的制备方法 |
Non-Patent Citations (1)
| Title |
|---|
| 葛洪如: "氧化稳定性高的植物营养调和油的配制", 《食品工业》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103444911A (zh) | 一种药食同源养生保健调和油 | |
| CN101884351B (zh) | 红花籽营养调和油 | |
| CN107712900A (zh) | 一种功能性中长链脂肪酸甘油酯微胶囊及其生产方法 | |
| CN111084381A (zh) | 生酮营养代餐粉及应用 | |
| CN104605034A (zh) | 一种营养植物调和油及其生产方法 | |
| CN109965026A (zh) | 一种促进儿童成长的配方奶粉及其制备方法 | |
| CN105341185A (zh) | 一种复合营养调和油及其制备方法 | |
| CN109337939B (zh) | 一种多不饱和脂肪酸结构脂质的制备方法 | |
| CN101919452B (zh) | 一种复合油保健食品 | |
| CN105054025A (zh) | 一种用于炎症性肠病患者的低脂低渗低渣型肠内营养粉剂 | |
| CN106962506A (zh) | 一种调和油及其制备方法 | |
| CN105707292A (zh) | 一种适用于婴幼儿的山茶调和油 | |
| CN104171025A (zh) | 一种适合妇女儿童的富硒食用油 | |
| CN101564180B (zh) | 一种核桃全营养素在制备益智和增强免疫力的药品或保健品中的应用 | |
| CN103750464A (zh) | 一种山菇益智功能饮料及其制备方法 | |
| CN105166733A (zh) | 一种秋季女生营养早餐粥 | |
| CN100574786C (zh) | 一种甲鱼制剂的生产工艺 | |
| CN108651635A (zh) | 具有健脑补脑功效的营养均衡的健康食用油 | |
| CN114931171A (zh) | 一种消炎、配比平衡的复合脂肪酸的营养品 | |
| Selvaraj et al. | Virgin coconut oil: A nutraceutical and therapeutic food | |
| Lee | Essent ial Fat ty Acids | |
| CN109527579A (zh) | 一种奇亚籽油制品及其制备方法和该奇亚籽油制品的应用 | |
| KR101548203B1 (ko) | 식물성 오메가 한방 발효환 제조방법 | |
| CN114009789A (zh) | 一种用于改善心脑血管疾病的食品及其制作工艺 | |
| Ustinova | Use of Natural Herbal Remedies as Immunity Protectors, Metabolically Similar to the Body |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220823 |
|
| RJ01 | Rejection of invention patent application after publication |